News-Medical.Net on MSN
Amyloid-clearing drug fails to change waste clearance function in the brains of Alzheimer's patients
A group from Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, found ...
Case Western University scientists were gifted $2.5 million to advance MS research into whether glial cells can be targeted to repair myelin.
Down syndrome results in changes to the structure and function of neural circuits in the brain. Delivering a specific protein ...
Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...
A group from Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, found ...
After lecanemab treatment, MRI scans show no short-term change in waste clearance function in Alzheimer’s patients ...
Scientists have discovered a new drug that offers "real hope" in the treatment of motor neurone disease (MND). The medicine, ...
Three research scientist entrepreneurs with roots in university labs and life sciences startup companies have announced ...
Full results from the Phase 2 REGEN-007 study of rilparencel were recently presented as a late-breaking clinical trial at the American Society of ...
Common ancestor eels lost the aquaporin gene encoding proteins with broad solute permeability. Researchers from Institute of ...
The anguish isn't over lost memories, but losing the people we love while still alive. The cruelest Alzheimer's symptom is ...
Topline results from pivotal HOPE-3 Phase 3 study (n=105) of Deramiocel for the treatment of Duchenne muscular dystrophy expected in the coming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results